These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 12839285)

  • 41. Renal failure affects the enzymatic activities of the three first steps in hepatic heme biosynthesis in the acute intermittent porphyria mouse.
    Unzu C; Sampedro A; Sardh E; Mauleón I; Enríquez de Salamanca R; Prieto J; Salido E; Harper P; Fontanellas A
    PLoS One; 2012; 7(3):e32978. PubMed ID: 22412963
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognosis of acute porphyria: occurrence of acute attacks, precipitating factors, and associated diseases.
    Kauppinen R; Mustajoki P
    Medicine (Baltimore); 1992 Jan; 71(1):1-13. PubMed ID: 1549056
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Understanding Carbohydrate Metabolism and Insulin Resistance in Acute Intermittent Porphyria.
    Solares I; Jericó D; Córdoba KM; Morales-Conejo M; Ena J; Enríquez de Salamanca R; Fontanellas A
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613492
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Porphobilinogen deaminase deficiency in mice causes a neuropathy resembling that of human hepatic porphyria.
    Lindberg RL; Porcher C; Grandchamp B; Ledermann B; Bürki K; Brandner S; Aguzzi A; Meyer UA
    Nat Genet; 1996 Feb; 12(2):195-9. PubMed ID: 8563760
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Prevention of acute intermittent porphyria is the best solution. Most important are early diagnosis and counseling].
    Floderus Y; Harper P; Henrichson A; Thunell S; Andersson D
    Lakartidningen; 1998 Jun; 95(26-27):3045-50. PubMed ID: 9679415
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Phase I open label liver-directed gene therapy clinical trial for acute intermittent porphyria.
    D'Avola D; López-Franco E; Sangro B; Pañeda A; Grossios N; Gil-Farina I; Benito A; Twisk J; Paz M; Ruiz J; Schmidt M; Petry H; Harper P; de Salamanca RE; Fontanellas A; Prieto J; González-Aseguinolaza G
    J Hepatol; 2016 Oct; 65(4):776-783. PubMed ID: 27212246
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mortality in patients with acute intermittent porphyria requiring hospitalization: a United States case series.
    Jeans JB; Savik K; Gross CR; Weimer MK; Bossenmaier IC; Pierach CA; Bloomer JR
    Am J Med Genet; 1996 Nov; 65(4):269-73. PubMed ID: 8923933
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Circadian rhythms in acute intermittent porphyria--a pilot study.
    Larion S; Caballes FR; Hwang SI; Lee JG; Rossman WE; Parsons J; Steuerwald N; Li T; Maddukuri V; Groseclose G; Finkielstein CV; Bonkovsky HL
    Eur J Clin Invest; 2013 Jul; 43(7):727-39. PubMed ID: 23650938
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular study of the hydroxymethylbilane synthase gene (HMBS) among Polish patients with acute intermittent porphyria.
    Gregor A; Schneider-Yin X; Szlendak U; Wettstein A; Lipniacka A; Rüfenacht UB; Minder EI
    Hum Mutat; 2002 Mar; 19(3):310. PubMed ID: 11857754
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Acute intermittent porphyria in 2 Moroccan families. Clinical and biological study].
    Aquaron R; Zarrouck K; el Boussaki A; Acquaviva JE
    Rev Med Interne; 1996; 17(6):477-81. PubMed ID: 8758536
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular analysis of acute intermittent porphyria: mutation screening in 20 patients in Germany reveals 11 novel mutations.
    von Brasch L; Zang C; Haverkamp T; Schlechte H; Heckers H; Petrides PE
    Blood Cells Mol Dis; 2004; 32(2):309-14. PubMed ID: 15003823
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Acute intermittent porphyria at the Hospital Arzobispo Loayza of Lima (1983-1994). A report of 14 cases].
    Bandrés Sánchez MP; Pamo Reyna OG
    Rev Gastroenterol Peru; 1994; 14(3):209-14. PubMed ID: 8000024
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genetic and biochemical characterization of 16 acute intermittent porphyria cases with a high prevalence of the R173W mutation.
    To-Figueras J; Badenas C; Carrera C; Muñoz C; Milá M; Lecha M; Herrero C
    J Inherit Metab Dis; 2006 Aug; 29(4):580-5. PubMed ID: 16817012
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Risk of primary liver cancer in acute hepatic porphyria patients: A matched cohort study of 1244 individuals.
    Lissing M; Vassiliou D; Floderus Y; Harper P; Bottai M; Kotopouli M; Hagström H; Sardh E; Wahlin S
    J Intern Med; 2022 Jun; 291(6):824-836. PubMed ID: 35112415
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Family study of acute intermittent porphyria and hereditary coproporphyria in Niigata and Akita Prefectures, Japan.
    Sasaki H; Kaneko K; Tsuneyama H; Daimon M; Yamatani K; Manaka H
    J Clin Epidemiol; 1996 Oct; 49(10):1117-23. PubMed ID: 8826991
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Brain magnetic resonance imaging white-matter lesions and cerebrospinal fluid findings in patients with acute intermittent porphyria.
    Bylesjö I; Brekke OL; Prytz J; Skjeflo T; Salvesen R
    Eur Neurol; 2004; 51(1):1-5. PubMed ID: 14631121
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hepatocyte transplantation ameliorates the metabolic abnormality in a mouse model of acute intermittent porphyria.
    Yin Z; Wahlin S; Ellis EC; Harper P; Ericzon BG; Nowak G
    Cell Transplant; 2014; 23(9):1153-62. PubMed ID: 23582197
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of acute intermittent porphyria carriers by molecular biologic methods.
    Bor M; Balogh K; Pusztai A; Tasnádi G; Hunyady L
    Acta Physiol Hung; 1999; 86(2):147-53. PubMed ID: 10741873
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Systemic inflammation in acute intermittent porphyria: a case-control study.
    Storjord E; Dahl JA; Landsem A; Fure H; Ludviksen JK; Goldbeck-Wood S; Karlsen BO; Berg KS; Mollnes TE; W Nielsen E; Brekke OL
    Clin Exp Immunol; 2017 Mar; 187(3):466-479. PubMed ID: 27859020
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Perplexing acute or chronic somatic or psychiatric symptoms: possibly due to porphyria].
    Schattenberg AV; de Pauw BE
    Ned Tijdschr Geneeskd; 1998 Aug; 142(32):1801-4. PubMed ID: 9856148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.